Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation

Blood

Volumn 92, Issue 2, 1998, Pages 672-682

  Garcia Sanchez, F ^b   Pizzorno, G ^b   Fu, S Q ^b   Nanakorn, T ^b   Krause, D S ^b   Liang, J ^b   Adams, E ^b   Leffert, J J ^b   Yin, L H ^b   Cooperberg, M R ^b   Hanania, E ^b   Wang, W L ^b   Won, J H ^b   Peng, X Y ^b   Cote, R ^b   Brown, R ^b   Burtness, B ^b   Giles, R ^b   Crystal, R ^b   Deisseroth, A B ^a  

^a YALE CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; VIRUS VECTOR;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG USE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL DEATH; CYTOSINE DEAMINASE; FEMALE; FLUCYTOSINE; FLUOROURACIL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; NUCLEOSIDE DEAMINASES; PRODRUGS; TRANSPLANTATION, AUTOLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032528436     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Peters WP: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: Yes. Important Adv Oncol 1:215, 1995
2. Dunphy RF, Spitzer G, Buzdar AU, Hortobagyi GN, Horowitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, Bohannan PA, Dicke KA: Treatment of estrogen receptor negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8:1207, 1990
3. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868, 1996
4. Myklebust AT, Godal A, Juell S, Pharo A, Fodstad O: Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow. Cancer Res 54:209, 1994
5. Tondini C, Pap SA, Hayes DF, Elias AD, Kufe DW: Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human marrow. Cancer Res 50:1170, 1990
6. Murgo AJ, Weinberger BB: Pharmacological bone marrow purging in autologous transplantation: Focus on the cyclophosphamide derivatives. Crit Rev Oncol Hematol 14:41, 1993
7. Chao NJ, Aihara M, Kuhl JS, Sikic BI, Blume KG: Purging multidrug resistant cells from bone marrow. Prog Clin Biol Res 377:13, 1992
8. Lemoli RM, Igarshi T, Knizewski M, Acaba L, Richter A, Jain A, Mitchell J, Gulati SC: Dye-mediated photolysis is capable of eliminating drug resistant (MDR+) tumor cells. Blood 81:793, 1993
9. Sphall EJ, Jones RB, Bearman SL, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hollogan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-postive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
10. Mullen CA, Kilstrup M, Blaese RM: Transfer of the bacterial gene for cytosine deaminase to a mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc Natl Acad Sci USA 89:33, 1992
11. Seth P, Brinkmann U, Schwartz GN, Katayose D, Gress R, Pastan I, Cowan K: Adenovirus mediated gene transfer to human breast tumor cells: An approach for cancer gene therapy and bone marrow purging. Cancer Res 56:1346, 1996
12. Clarke MF, Apel IJ, Benedict MNA, Eipers PG, Sumantran V, Gonzalez-Garcia M, Doedens J, Fukunage B, Davidson B, Dick J, Minn AJ, Boise LH, Thompson CB, Wicha M, Nunez G: A recombinant BCL-Xshort adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 92:11024, 1995
13. Neering SJ, Harhy SF, Minamoto D, Spratt S, Jordan DT: Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 87:1147, 1996
14. Watanabe T, Kuszynski C, Ino K, Heimann DG, Shepard HM, Yasui Y, Maneval DC, Talmadge JE: Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vector. Blood 87:5032, 1996
15. Nord JD, Stolfi RL, Martin DS: Biochemical modulation of 5-FU with leucovorin or delayed uridine rescue. Biochem Pharmacol 43: 2543, 1992
16. Armstrong RD, Lewis M, Stern SG, Cadman EC: Acute effect of 5-FU on cytoplasmic and nuclear dihydrofolate reductase mRNA metabolism. J Biol Chem 261:72366, 1986
17. Pizzorno G, Sun Z, Handschumacher RE: Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-FU. Biochem Pharmacol 49:553, 1995
18. Huber BE, Austin EA, Richards CA, Davis ST, Good SS: Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 91:8302, 1994
19. Hirschowitz EA, Ohwada A, Pascal WR, Russi TJ, Crystal RG: In vivo adenovirus mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma derived tumors induces chemosensitivity to 5-FC. Hum Gene Ther 6:1055, 1995
20. Graham FL, Prevec L: Manipulation of adenovirus vectors, in Murray EJ (ed): Methods in Molecular Biology, Gene Transfer and Expression Protocols, Vol 7. Clifton, NJ, Humana, 1991, p 109
21. Berger CN, Tan S, Sturm KS: Simultaneous detection of β-galactosidase activity and surface antigen expression in variable hematopoietic cells. Cytometry 17:216, 1994
22. Fiering SN, Roederer M, Nolan GP, Micklem DR, Parks DR, Herzenberg LA: Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry 12:291, 1991
23. Mathias P, Wickham T, Moore M, Nemerow G: Multiple adenovirus serotypes use alpha v integrins for infection. J Virol 68:6811, 1994
24. 5 promote adenovirus internalization but not virus attachment. Cell 73:309, 1993
25. Hanania EG, Giles RE, Kavanagh J, Ellerson D, Zu Z, Wang T, Su Y, Kudelka A, Rahman Z, Golmes F, Hortobagyi G, Claxton D, Bachier C, Thall P, Cheng S, Hester J, Ostrove J, Bird R, Chang A, Korbling M, Seong D, Cote R, Holzmayer T, Mechetner E, Heimfeld S, Berenson R, Burtness B, Edwards C, Bast R, Andreeff M, Champlin R, Deisseroth A: Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to post-transplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 93:15346, 1996
26. Berardi AC, Wang A, Levine JD, Lopez R Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 267:104, 1995
27. Liapis H, Flath A, Kitazawa S: Integrin alpha V beta 3 expression by bone residing breast cancer metastases. Diag Mol Pathol 5:127, 1993
28. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WV, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Brenner M, Hamer J, Calvert I, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
29. Brenner MK, Rill DR, Holiday MS, Heels HE, Moen RC, Bustle M, Crank RA, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
30. Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK: Retrovirus mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther 3:129, 1992
31. Chen L, Pulshipher M, Chen D, Sieff C, Elias A, Fine HA, Kufe DW: Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 98:2539, 1996